Via Transportation, Inc.
US ˙ NYSE ˙ US92556D3044

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Paul T Quinlan. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Paul T Quinlan har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
General Counsel 31.767
US:CBAY / CymaBay Therapeutics, Inc. General Counsel 0
US:TVIA / TerraVia Holdings, Inc. General Counsel 218.403
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Paul T Quinlan. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb VIA / Via Transportation, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VIA / Via Transportation, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VIA / Via Transportation, Inc. Insider Trades
Insidersalg VIA / Via Transportation, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VIA / Via Transportation, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VIA / Via Transportation, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Paul T Quinlan som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-03-17 2026-03-16 4 ORKA Oruka Therapeutics, Inc.
Common Stock
S - Sale -733 31.767 -2,26 41,30 -30.273 1.311.977
2026-01-23 2026-01-23 4 ORKA Oruka Therapeutics, Inc.
Common Stock
A - Award 32.500 32.500
2024-03-22 2024-03-22 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
D - Sale to Issuer -28.438 0 -100,00
2024-03-22 2024-03-22 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
D - Sale to Issuer -41.824 0 -100,00
2024-03-15 2024-03-13 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 41.824 70.262 147,07 7,89 329.991 554.367
2024-01-26 2024-01-24 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
A - Award 28.438 28.438
2024-01-16 2024-01-16 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 23,58 -117.898
2024-01-16 2024-01-16 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-12-15 2023-12-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 21,98 -109.902
2023-12-15 2023-12-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-11-17 2023-11-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 17,38 -86.889
2023-11-17 2023-11-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-10-18 2023-10-16 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 13,76 -68.798
2023-10-18 2023-10-16 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-09-19 2023-09-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -24.000 0 -100,00 16,87 -404.916
2023-09-19 2023-09-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 24.000 24.000 2,94 70.560 70.560
2023-09-19 2023-09-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 24.000 24.000 2,94 70.560 70.560
2023-09-19 2023-09-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -24.000 0 -100,00 16,87 -404.897
2023-09-19 2023-09-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 16,87 -84.328
2023-09-19 2023-09-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-08-16 2023-08-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 11,91 -59.550
2023-08-16 2023-08-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-07-14 2023-07-14 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 11,81 -59.050
2023-07-14 2023-07-14 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-06-30 2023-06-30 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 10,05 -50.250
2023-06-30 2023-06-30 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2023-05-17 2023-05-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 10,37 -51.831
2023-05-17 2023-05-15 4 CBAY CymaBay Therapeutics, Inc.
Common Stock
M - Exercise 5.000 5.000 2,94 14.700 14.700
2022-01-27 2022-01-25 4 CBAY CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 200.000 200.000
2021-01-28 2021-01-26 4 CBAY CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 22.167 22.167
2020-10-14 2020-10-12 4 CBAY CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 275.000 275.000
2019-01-31 2019-01-29 4 CBAY CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 86.445 86.445
2018-01-26 2018-01-24 4 CBAY CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 50.000 50.000
2018-01-26 2018-01-24 4 CBAY CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 250.000 250.000
2017-03-13 2017-03-09 4 TVIA TerraVia Holdings, Inc.
Common Stock
S - Sale X -25.000 218.403 -10,27 0,81 -20.232 176.754
2017-02-08 2017-02-06 4 TVIA TerraVia Holdings, Inc.
Employee Stock Option (right to buy)
A - Award 200.000 200.000
2017-02-08 2017-02-06 4 TVIA TerraVia Holdings, Inc.
Common Stock
A - Award 23.000 243.403 10,44
2017-02-08 2017-02-06 4 TVIA TerraVia Holdings, Inc.
Common Stock
A - Award 100.000 220.403 83,05
2016-10-14 2016-10-14 4 TVIA TerraVia Holdings, Inc.
Common Stock
S - Sale X -10.000 120.403 -7,67 2,55 -25.528 307.365
2016-09-16 2016-09-16 4 TVIA TerraVia Holdings, Inc.
Common Stock
S - Sale X -3.124 130.528 -2,34 2,60 -8.127 339.582
2016-09-15 2016-09-13 4 TVIA TerraVia Holdings, Inc.
Common Stock
S - Sale X -1.562 133.652 -1,16 2,74 -4.273 365.605
2016-03-14 2016-03-10 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -4.686 133.007 -3,40 1,64 -7.666 217.599
2016-03-09 2016-03-08 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 350.000 350.000
2016-03-09 2016-03-08 4 SZYM SOLAZYME INC
Common Stock
A - Award 62.500 137.693 83,12
2016-03-09 2016-03-08 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -1.562 75.193 -2,04 1,66 -2.600 125.166
2015-09-17 2015-09-17 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -1.562 76.755 -1,99 3,14 -4.911 241.310
2015-09-17 2015-09-15 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -1.562 78.317 -1,96 3,08 -4.814 241.389
2015-03-11 2015-03-09 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -9.687 79.879 -10,82 2,69 -26.098 215.202
2015-03-05 2015-03-03 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 22.636 22.636
2015-03-04 2015-03-03 4 SZYM SOLAZYME INC
Common Stock
A - Award 25.000 89.566 38,72
2015-03-04 2015-03-02 4 SZYM SOLAZYME INC
Common Stock
F - Taxes -5.747 64.566 -8,17 2,67 -15.344 172.391
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 27.500 27.500
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
D - Sale to Issuer -55.000 0 -100,00
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 25.001 25.001
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
D - Sale to Issuer -50.000 0 -100,00
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 50.000 50.000
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
D - Sale to Issuer -100.000 0 -100,00
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 30.000 30.000
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
D - Sale to Issuer -60.000 0 -100,00
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 20.000 20.000
2015-02-20 2015-02-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
D - Sale to Issuer -40.000 0 -100,00
2014-12-22 2014-12-18 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 137.500 137.500
2014-09-11 2014-09-09 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -16.562 70.313 -19,06 8,53 -141.237 599.615
2014-08-19 2014-08-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -6.000 22.000 -21,43
2014-08-19 2014-08-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 86.875 -6,46 9,55 -57.281 829.387
2014-08-19 2014-08-19 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 6.000 92.875 6,91 2,35 14.100 218.256
2014-08-19 2014-08-15 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.500 86.875 -2,80 9,13 -22.834 793.464
2014-07-22 2014-07-21 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -6.000 28.000 -17,65
2014-07-22 2014-07-21 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 86.875 -6,46 9,80 -58.777 851.045
2014-07-22 2014-07-21 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 6.000 92.875 6,91 2,35 14.100 218.256
2014-06-20 2014-06-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -6.000 34.000 -15,00
2014-06-20 2014-06-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 86.875 -6,46 11,99 -71.963 1.041.961
2014-06-20 2014-06-19 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 6.000 92.875 6,91 2,35 14.100 218.256
2014-05-19 2014-05-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -6.000 40.000 -13,04
2014-05-19 2014-05-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 86.875 -6,46 9,20 -55.218 799.511
2014-05-19 2014-05-19 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 6.000 92.875 6,91 2,35 14.100 218.256
2014-04-21 2014-04-21 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -6.000 46.000 -11,54
2014-04-21 2014-04-21 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 86.875 -6,46 11,33 -67.994 984.494
2014-04-21 2014-04-21 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 6.000 92.875 6,91 2,35 14.100 218.256
2014-03-19 2014-03-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -6.000 52.000 -10,34
2014-03-19 2014-03-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 86.875 -6,46 14,39 -86.356 1.250.357
2014-03-19 2014-03-19 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 6.000 92.875 6,91 2,35 14.100 218.256
2014-03-04 2014-03-04 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -3.125 86.875 -3,47 12,21 -38.147 1.060.483
2014-02-24 2014-02-24 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -6.000 58.000 -9,38
2014-02-24 2014-02-24 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -8.239 90.000 -8,39 11,61 -95.682 1.045.197
2014-02-24 2014-02-24 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 6.000 98.239 6,50 2,35 14.100 230.862
2014-02-14 2014-02-12 4 SZYM SOLAZYME INC
Common Stock
A - Award 55.000 55.000
2014-02-14 2014-02-12 4 SZYM SOLAZYME INC
Common Stock
A - Award 25.000 90.000 38,46
2014-01-22 2014-01-21 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 65.000 -8,45 10,47 -62.845 680.816
2013-12-19 2013-12-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 71.000 -7,79 9,40 -56.407 667.485
2013-11-19 2013-11-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 77.000 -7,23 8,41 -50.459 647.555
2013-10-21 2013-10-21 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 83.000 -6,74 11,47 -68.820 952.010
2013-09-19 2013-09-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -6.000 89.000 -6,32 10,73 -64.370 954.828
2013-08-16 2013-08-16 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -739 95.000 -0,77 11,89 -8.787 1.129.550
2013-06-21 2013-06-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -3.000 64.000 -4,48
2013-06-21 2013-06-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -3.000 95.000 -3,06 12,04 -36.129 1.144.085
2013-06-21 2013-06-19 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 3.000 98.000 3,16 2,35 7.050 230.300
2013-05-21 2013-05-20 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -3.000 67.000 -4,29
2013-05-21 2013-05-20 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -3.000 95.000 -3,06 11,17 -33.508 1.061.093
2013-05-21 2013-05-20 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 3.000 98.000 3,16 2,35 7.050 230.300
2013-05-10 2013-05-10 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -21.000 70.000 -23,08
2013-05-10 2013-05-10 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -21.000 95.000 -18,10 10,00 -210.000 950.000
2013-05-10 2013-05-10 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 21.000 116.000 22,11 2,35 49.350 272.600
2013-02-27 2013-02-25 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
A - Award 50.000 50.000
2013-02-27 2013-02-25 4 SZYM SOLAZYME INC
Common Stock
A - Award 40.000 95.000 72,73
2013-02-27 2013-02-25 4 SZYM SOLAZYME INC
Common Stock
A - Award 25.000 55.000 83,33
2012-10-12 2012-10-12 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -2.000 91.000 -2,15
2012-10-12 2012-10-12 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 10,24 -20.488 307.317
2012-10-12 2012-10-12 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-09-20 2012-09-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -3.000 95.000 -3,06
2012-09-20 2012-09-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -3.000 30.000 -9,09 11,39 -34.172 341.721
2012-09-20 2012-09-19 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 3.000 33.000 10,00 2,35 7.050 77.550
2012-09-13 2012-09-12 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -2.000 96.000 -2,04
2012-09-13 2012-09-12 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 11,44 -22.871 343.059
2012-09-13 2012-09-12 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-08-20 2012-08-20 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -3.000 98.000 -2,97
2012-08-20 2012-08-20 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -3.000 30.000 -9,09 13,17 -39.502 395.025
2012-08-20 2012-08-20 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 3.000 33.000 10,00 2,35 7.050 77.550
2012-08-13 2012-08-13 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -2.000 101.000 -1,94
2012-08-13 2012-08-13 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 11,89 -23.774 356.610
2012-08-13 2012-08-13 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-07-20 2012-07-19 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -3.000 103.000 -2,83
2012-07-20 2012-07-19 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -3.000 30.000 -9,09 13,51 -40.515 405.153
2012-07-20 2012-07-19 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 3.000 33.000 10,00 2,35 7.050 77.550
2012-07-12 2012-07-12 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -2.000 106.000 -1,85
2012-07-12 2012-07-12 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 11,42 -22.842 342.630
2012-07-12 2012-07-12 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-06-13 2012-06-12 4 SZYM SOLAZYME INC
Employee Stock Option (right to buy)
M - Exercise -2.000 108.000 -1,82
2012-06-13 2012-06-12 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 12,23 -24.451 366.765
2012-06-13 2012-06-12 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-05-14 2012-05-14 4 SZYM SOLAZYME INC
Employee stock option (right to buy)
M - Exercise -2.000 110.000 -1,79
2012-05-14 2012-05-14 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 10,06 -20.126 301.890
2012-05-14 2012-05-14 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-04-12 2012-04-12 4 SZYM SOLAZYME INC
Employee stock option (right to buy)
M - Exercise -2.000 112.000 -1,75
2012-04-12 2012-04-12 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 12,81 -25.626 384.390
2012-04-12 2012-04-12 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-03-13 2012-03-12 4 SZYM SOLAZYME INC
Employee stock option (right to buy)
M - Exercise -2.000 114.000 -1,72
2012-03-13 2012-03-12 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 13,97 -27.941 419.115
2012-03-13 2012-03-12 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-03-06 2012-03-02 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.500 30.000 -7,69 13,13 -32.836 394.026
2012-02-13 2012-02-13 4 SZYM SOLAZYME INC
Employee stock option (right to buy)
M - Exercise -2.000 116.000 -1,69
2012-02-13 2012-02-13 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 11,30 -22.591 338.868
2012-02-13 2012-02-13 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
2012-02-13 2012-02-11 4 SZYM SOLAZYME INC
Employee stock option (right to buy)
A - Award 100.000 100.000
2012-01-12 2012-01-12 4 SZYM SOLAZYME INC
Employee stock option (right to buy)
M - Exercise -2.000 118.000 -1,67
2012-01-12 2012-01-12 4 SZYM SOLAZYME INC
Common Stock
S - Sale X -2.000 30.000 -6,25 11,16 -22.326 334.890
2012-01-12 2012-01-12 4 SZYM SOLAZYME INC
Common Stock
M - Exercise 2.000 32.000 6,67 2,35 4.700 75.200
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)